Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BIOA compared with DRUG: revenue, margins and what each company keeps, and the suppliers and customers both name
BIOA
BioAge Labs, Inc.
Change
Mkt cap
Revenue
Revenue
DRUG
Bright Minds Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BIOA
BioAge Labs, Inc.
vs
DRUG
Bright Minds Biosciences Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
BIOA, solid
DRUG, dashed
BIOA
BioAge Labs, Inc.
Change
5.30
▼
−4.38%
· post 5.30
Mkt cap
$245.2M
Revenue
$298,000
Q3 FY26
Revenue
$9M
FY25
DRUG
Bright Minds Biosciences Inc.
Change
22.87
▲
+10.48%
· post 22.66
Closed
Nov 6 '26
Mkt cap
$175.6M
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 6 '26
BIOA
BioAge Labs, Inc.
vs
DRUG
Bright Minds Biosciences Inc.
5.30
▼
−4.38%
post 5.30
Price
22.87
▲
+10.48%
post 22.66
$245.2M
Mkt cap
$175.6M
Q3 FY26
$298,000
Revenue
—
FY25
$9M
Revenue
—
Change
Change
BIOA
5.30
▼
−4.38%
vs
DRUG
22.87
▲
+10.48%
Closed
Nov 6 '26